Increased expression of ZNF 703 in breast cancer tissue: An opportunity for RNAi –NSAID combinatorial therapy

We report that the combination of anti‐ZNF703 RNAi with ibuprofen as the inhibitor of COX‐2 is highly effective in inhibiting MCF‐7 as a breast cancer cell line and shows therapeutic potential for breast cancer.

Source: Biotechnology and Applied Biochemistry - June 23, 2019 Category: Biochemistry Authors: Marzieh Marzbany, Anupam Bishayee, Mahsa Rasekhian Tags: Original Article Source Type: research